The correlation between the ongoing inflammation in the body and its markers (CRP, IL-6, prohepcidine) and Fe levels was confirmed by the study by Stefanova et al. [102], which was conducted on a group of 114 patients with RA, whose serum Fe levels were significantly lower than that of the control group. The gene discussed is IL6; the disease is rheumatoid arthritis.